Cited by

• Comparison of microRNA expression levels between initial and recurrent glioblastoma specimens.

  Ilhan-Mutlu A, Wöhrer A, Berghoff AS, Widhalm G, Marosi C, Wagner L, Preusser M. Ilhan-Mutlu A, et al. J Neurooncol. 2013 May;112(3):347-54. doi: 10.1007/s11060-013-1078-6. Epub 2013 Feb 19. J Neurooncol. 2013. PMID: 23420397
• Increased diffusion in the normal appearing white matter of brain tumor patients: is this just tumor infiltration?

  Horváth A, Perlaki G, Tóth A, Orsi G, Nagy S, Dóczi T, Horváth Z, Bogner P. Horváth A, et al. J Neurooncol. 2016 Mar;127(1):83-90. doi: 10.1007/s11060-015-2011-y. Epub 2015 Nov 27. J Neurooncol. 2016. PMID: 26614516
• Radiotherapy induces an immediate inflammatory reaction in malignant glioma: a clinical microdialysis study.

  Tabatabaei P, Visse E, Bergström P, Brännström T, Siesjö P, Bergenheim AT. Tabatabaei P, et al. J Neurooncol. 2017 Jan;131(1):83-92. doi: 10.1007/s11060-016-2271-1. Epub 2016 Sep 23. J Neurooncol. 2017. PMID: 27664151 Free PMC article.
• Volumetric and MGMT parameters in glioblastoma patients: survival analysis.

  Iliadis G, Kotoula V, Chatzisotiriou A, Televantou D, Eleftheraki AG, Lambaki S, Misailidou D, Selviaridis P, Fountzilas G. Iliadis G, et al. BMC Cancer. 2012 Jan 3;12:3. doi: 10.1186/1471-2407-12-3. BMC Cancer. 2012. PMID: 22214427 Free PMC article.
• Assessing the predictability of IDH mutation and MGMT methylation status in glioma patients using relaxation-compensated multipool CEST MRI at 7.0 T.

  Paech D, Windschuh J, Oberhollenzer J, Dreher C, Sahm F, Meissner JE, Goerke S, Schuenke P, Zaiss M, Regnery S, Bickelhaupt S, Bäumer P, Bendszus M, Wick W, Unterberg A, Bachert P, Ladd ME, Schlemmer HP, Radbruch A. Paech D, et al. Neuro Oncol. 2018 Nov 12;20(12):1661-1671. doi: 10.1093/neuonc/noy073. Neuro Oncol. 2018. PMID: 29733378 Free PMC article.